Columbia Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.2M | Sell |
110,475
-1,188
| -1% | -$139K | 2.47% | 10 |
|
|
2026
Q1 | $13.4M | Buy |
111,663
+129
| +0.1% | +$14.9K | 2.56% | 8 |
|
|
2025
Q4 | $11.7M | Sell |
111,534
-1,605
| -1% | -$151K | 2.09% | 9 |
|
|
2025
Q3 | $9.5M | Sell |
113,139
-2,413
| -2% | -$199K | 1.78% | 10 |
|
|
2025
Q2 | $9.15M | Sell |
115,552
-7,096
| -6% | -$564K | 1.8% | 11 |
|
|
2025
Q1 | $11M | Sell |
122,648
-7,731
| -6% | -$722K | 2.15% | 7 |
|
|
2024
Q4 | $13M | Sell |
130,379
-4,231
| -3% | -$436K | 2.37% | 8 |
|
|
2024
Q3 | $15.3M | Sell |
134,610
-4,782
| -3% | -$568K | 2.66% | 7 |
|
|
2024
Q2 | $17.3M | Sell |
139,392
-628
| -0.4% | -$80.9K | 3.22% | 5 |
|
|
2024
Q1 | $15.3M | Hold |
140,020
| – | – | 3.1% | 5 |
|
|
2023
Q4 | $15.3M | Sell |
140,020
-1,281
| -0.9% | -$133K | 3.1% | 5 |
|
|
2023
Q3 | $14.5M | Sell |
141,301
-1,587
| -1% | -$171K | 3.21% | 4 |
|
|
2023
Q2 | $16.5M | Sell |
142,888
-5,335
| -4% | -$606K | 3.51% | 4 |
|
|
2023
Q1 | $15.8M | Sell |
148,223
-1,092
| -0.7% | -$118K | 3.55% | 4 |
|
|
2022
Q4 | $16.6M | Buy |
149,315
+87
| +0.1% | +$8.89K | 4.02% | 4 |
|
|
2022
Q3 | $12.9M | Buy |
149,228
+2,974
| +2% | +$265K | 3.38% | 4 |
|
|
2022
Q2 | $13.3M | Buy |
+146,254
| New | +$13M | 3.38% | 4 |
|
|
2021
Q4 | $11.3M | Buy |
147,466
+858
| +0.6% | +$68.3K | 2.29% | 8 |
|
|
2021
Q3 | $11M | Buy |
146,608
+1,881
| +1% | +$143K | 2.4% | 8 |
|
|
2021
Q2 | $11.3M | Sell |
144,727
-21,161
| -13% | -$1.57M | 2.5% | 6 |
|
|
2021
Q1 | $12.2M | Buy |
165,888
+1,501
| +0.9% | +$111K | 2.21% | 9 |
|
|
2020
Q4 | $12.8M | Buy |
164,387
+821
| +0.5% | +$62.8K | 2.59% | 7 |
|
|
2020
Q3 | $12.9M | Buy |
163,566
+2,056
| +1% | +$161K | 2.97% | 4 |
|
|
2020
Q2 | $11.9M | Sell |
161,510
-708
| -0.4% | -$53.3K | 2.85% | 5 |
|
|
2020
Q1 | $11.9M | Buy |
162,218
+1,765
| +1% | +$139K | 2.94% | 5 |
|
|
2019
Q4 | $139K | Sell |
160,453
-108
| -0.1% | -$8.87K | 3.36% | 3 |
|
|
2019
Q3 | $12.9M | Buy |
160,561
+1,027
| +0.6% | +$82.3K | 3.36% | 3 |
|
|
2019
Q2 | $12.8M | Sell |
159,534
-975
| -0.6% | -$74.7K | 3.36% | 4 |
|
|
2019
Q1 | $12.7M | Sell |
160,509
-43
| -0% | -$3.22K | 3.4% | 3 |
|
|
2018
Q4 | $11.7M | Sell |
160,552
-3,212
| -2% | -$227K | 3.56% | 3 |
|
|
2018
Q3 | $11.1M | Buy |
163,764
+689
| +0.4% | +$43.9K | 2.89% | 3 |
|
|
2018
Q2 | $9.45M | Sell |
163,075
-641
| -0.4% | -$36.2K | 2.75% | 3 |
|
|
2018
Q1 | $8.51M | Buy |
163,716
+1,611
| +1% | +$87K | 2.5% | 6 |
|
|
2017
Q4 | $8.7M | Sell |
162,105
-323
| -0.2% | -$17.9K | 2.5% | 6 |
|
|
2017
Q3 | $9.92M | Sell |
162,428
-791
| -0.5% | -$48K | 3.05% | 4 |
|
|
2017
Q2 | $9.98M | Sell |
163,219
-132
| -0.1% | -$8.04K | 3.22% | 3 |
|
|
2017
Q1 | $9.9M | Sell |
163,351
-677
| -0.4% | -$41.1K | 3.32% | 2 |
|
|
2016
Q4 | $9.21M | Buy |
164,028
+132
| +0.1% | +$7.72K | 3.11% | 3 |
|
|
2016
Q3 | $9.76M | Sell |
163,896
-1,156
| -0.7% | -$67.6K | 3.42% | 3 |
|
|
2016
Q2 | $9.07M | Buy |
165,052
+2,555
| +2% | +$136K | 3.23% | 2 |
|
|
2016
Q1 | $8.2M | Buy |
162,497
+2,774
| +2% | +$136K | 3.01% | 4 |
|
|
2015
Q4 | $8.05M | Buy |
159,723
+1,136
| +0.7% | +$57.3K | 3.23% | 5 |
|
|
2015
Q3 | $7.47M | Buy |
158,587
+3,438
| +2% | +$183K | 3.04% | 4 |
|
|
2015
Q2 | $8.43M | Sell |
155,149
-210
| -0.1% | -$11.8K | 3.21% | 3 |
|
|
2015
Q1 | $8.52M | Buy |
155,359
+493
| +0.3% | +$27.9K | 3.21% | 2 |
|
|
2014
Q4 | $8.39M | Sell |
154,866
-4,307
| -3% | -$240K | 3.23% | 2 |
|
|
2014
Q3 | $9M | Sell |
159,173
-503
| -0.3% | -$28.2K | 3.64% | 1 |
|
|
2014
Q2 | $8.81M | Sell |
159,676
-131
| -0.1% | -$7.15K | 3.57% | 1 |
|
|
2014
Q1 | $8.66M | Buy |
159,807
+262
| +0.2% | +$13.6K | 3.77% | 1 |
|
|
2013
Q4 | $7.62M | Buy |
+159,545
| New | +$7.29M | 3.37% | 1 |
|
Other funds holding MRK
ECSS
Columbia Asset Management's MRK Position: Q2 2026 in Review
Columbia Asset Management reduced its Merck (MRK) stake by 1.1% in Q2 2026, selling an estimated $139K and leaving 110,475 shares worth $14.2M. The position accounts for 2.47% of the portfolio, ranked #10.
Columbia Asset Management first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $17.3M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Columbia Asset Management held 110,475 shares of Merck worth $14.2M as of Q2 2026.
- Columbia Asset Management sold 1,188 Merck shares in Q2 2026, an estimated $139K.
- Merck made up 2.47% of Columbia Asset Management's portfolio in Q2 2026, its #10 holding.
- Columbia Asset Management first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
- Columbia Asset Management's Merck position peaked at $17.3M in Q2 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Columbia Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.